Monthly Archives: June 2009

Updated: An End to the US Ban on HIV-positive Visitors?

By on .

Updated: The Obama administration has taken a key step toward lifting a two-decades-old ban on travel and immigration to the US by HIV-positive foreigners, which has long been criticized as unnecessary and discriminatory. When Congress reauthorized the PEPFAR program last summer, lawmakers included a provision overturning the ban that barred HIV-positive visitors from the US. But the prohibition […]

Deadly Duo Briefing: TB is the Biggest Threat to the "Miracle of HIV Therapy"

By on .

Update: A full video of the briefing appears at the bottom of the post. Leading disease experts made a compelling case for strong US leadership and aggressive new policies to combat HIV/TB co-infection at a congressional briefing on Thursday. The briefing came in conjunction with the release of a new report, “Deadly Duo: The Synergy […]

Update: House Spending Committee Boosts Funding for Global HIV & TB

By on .

Global health programs targeting HIV/AIDS and tuberculosis got a surprise boost on Tuesday when the House Appropriations Committee took up the foreign affairs spending bill. Rep. Nita Lowey, D-N.Y., successfully offered an amendment adding $50 million to global TB programs, a welcome move particularly given growing threat of drug-resistant TB. This boost followed a letter […]

Debate Over Obama's Global Health Initiative Heats Up

By on .

Update: Click play below to listen to the interview with Center for Global Health Policy head Christine Lubinski. $63 billion sounds like a lot of money. That’s the price tag on President Barack Obama’s global health initiative, unveiled with some fanfare last month and the target of contentious debate ever since. But how far will […]

A Call for Urgent Action to Address HIV/TB Co-infection

By on .

Leading disease experts will call on President Obama and Congress to mount a concerted and comprehensive response to the deadly alliance between HIV/AIDS and tuberculosis at a Capitol Hill briefing this Thursday, June 25.  The call to action from America’s top HIV/TB scientists and physicians comes in conjunction with the release of a new report, […]

HIV/TB Specialists Needed

By on .

Doctors Without Borders needs HIV and TB specialists to work in 35 countries, doing patient care, training and management. Here’s the posting and a link for more info: PUT YOUR IDEALS INTO PRACTICE: DOCTORS WITHOUT BORDERS SEEKS HIV/AIDS and TB SPECIALISTS Doctors Without Borders provides assistance to people whose survival is threatened by epidemics, violence, […]

Goosby wins Senate confirmation

By on .

Finally, a strong and seasoned voice in the White House to defend global AIDS spending and advance the President’s Emergency Plan for AIDS Relief (PEPFAR). The full Senate confirmed Dr. Eric Goosby to be the new the U.S. Global AIDS Coordinator on Friday. As we said in a news release applauding the vote, Congress now needs […]

Lancet Articles Fire Up Fresh Debate Over Global Health Programs

By on .

The long-simmering debate over the impact of disease-specific programs on health-system strengthening may have just reached a boil. Today’s Lancet features an in-depth exploration of the impact of global health programs, particularly those aimed at tackling HIV/AIDS, tuberculosis and malaria. The debate has gained steam in recent weeks, since the White House announced its new […]

At MDR-TB summit's end, expressions of frustration

By on .

This live blog is from the Pacific Health Summit in Seattle, a three-day meeting that opened Tuesday night. Its focus is the global response to multidrug-resistant tuberculosis. The Pacific Health Summit ended today with expressions of frustration from both activists and global leaders in the world’s lack of progress against tuberculosis — especially controlling drug-resistant […]

The question of universal access for TB patients

By on .

This live blog is from the Pacific Health Summit in Seattle, a three-day meeting that opened Tuesday night. Its focus is the global response to multidrug-resistant tuberculosis. In the world of HIV/AIDS, a long rallying cry has been universal access for treatment. Now it’s coming to the world of TB – and likely for other […]